Dental Management of Patients With Haemophilia in the Era of Recombinant Treatments: Increased Efficacy and Decreased Clinical Risk

BMJ Case Reports - United Kingdom
doi 10.1136/bcr-2018-227974
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

BMJ

Related search

A Protocol for the Dental Management of Von Willebrand's Disease, Haemophilia a and Haemophilia B

Australian Dental Journal
Dentistry
2001English

Management of Haemophilia B Patients With Inhibitors and Anaphylaxis

Haemophilia
MedicineGeneticsHematology
1998English

Dental Considerations in a Patient With Haemophilia

The Journal of Haemophilia Practice
2016English

Clinical Efficacy and Safety of SB309, a Biosimilar Recombinant Human Erythropoietin, in the Management of Anemia

Biosimilars
2013English

Recombinant Factor VIIa for the Prevention and Treatment of Bleeding in Patients Without Haemophilia

2007English

Postmarketing Safety and Effectiveness of Recombinant Factor IX (Nonacog Alfa) in Japanese Patients With Haemophilia B

Haemophilia
MedicineGeneticsHematology
2019English

Clinical Efficacy of Chelation Therapy in Patients With Low-Risk Myelodysplastic Syndrome

Klinicheskaya Onkogematologiya/Clinical Oncohematology
OncologyHematology
2019English

020 Increased Risk of an Abnormal Cervical Screening Test in Women With MS Exposed to High-Efficacy Disease-Modifying Treatments

Journal of Neurology, Neurosurgery and Psychiatry
PsychiatryMental HealthNeurologySurgery
2019English

Clinical Findings and Treatments of Patients With Zenker's Diverticulum

Japanese Journal of Gastroenterological Surgery
SurgeryGastroenterology
2004English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy